Skip to main content

Table 3 Round 1 descriptive statistics

From: Clinical indicators to identify neuropathic pain in low back related leg pain: a modified Delphi study

Round 1 criteria for consensus:

✓ Median value of participants Likert scale data ≥ 3

✓ Percentage of agreement 50% (Wiangkham et al., 2016 [25])

Clinical indicator

Median

Percentage of agreement

Consensus achieved

Pain variously described as burning, shooting, sharp, aching or electric-shock-like

4

85.7%

Y

History of nerve injury, pathology or mechanical compromise

4

77.2%

Y

Pain in association with other neurological symptoms (e.g. pins and needles, numbness, weakness)

4

77.2%

Y

Pain referred in a dermatomal or cutaneous distribution

3

48%

N

Less responsive to simple analgesia/NSAIDS and/or more responsive to anti-epileptic (e.g. Neurontin, Lyrica)/anti-depression (e.g. Amitriptyline) medication

3

39%

N

Pain of high severity and irritability (i.e. easily provoked, taking longer to settle)

4

54.3%

Y

Mechanical pattern to aggravating and easing factors involving activities/postures associated with movements, loading or compression of neural tissue

3

42.9%

N

Pain in association with other dysesthesias (e.g. crawling, electrical, heaviness)

4

68.6%

Y

Reports of spontaneous pain (i.e. stimulus independent) and/or paroxysmal pain (i.e. sudden recurrences and intensification of pain)

4

51.4%

Y

Pain/symptom provocation with mechanical/movement tests (e.g. Active/Passive, Neurodynamic, i.e. SLR, Brachial plexus tension test) that move/load/compress neural tissue

4

65.7%

Y

Pain/symptom provocation on palpation of relevant neural tissues

4

51.4%

Y

Positive neurological signs (including altered reflexes, sensation and muscle power in dermatomal/myotomal or cutaneous nerve distribution)

4

63.8%

Y

Antalgic posturing of the affected limb/body part

2

37.1%

N

Positive findings of hyperalgesia (primary or secondary) and/or allodynia and/or hyperpathia within the distribution of pain

4

57.2%

Y